Oramed to Present at the H.C. Wainwright Global Investment Conference

NEW YORK, Aug. 28, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com),  a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming H.C. Wainwright 20th Annual Global Investment Conference, taking place September 4-6, 2018 in New York City.  Nadav […]